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Abstract
Identification of protein domains is a key step for understanding protein function. Hidden Markov Models (HMMs) have
proved to be a powerful tool for this task. The Pfam database notably provides a large collection of HMMs which are widely
used for the annotation of proteins in sequenced organisms. This is done via sequence/HMM comparisons. However, this
approach may lack sensitivity when searching for domains in divergent species. Recently, methods for HMM/HMM
comparisons have been proposed and proved to be more sensitive than sequence/HMM approaches in certain cases.
However, these approaches are usually not used for protein domain discovery at a genome scale, and the benefit that could
be expected from their utilization for this problem has not been investigated. Using proteins of P. falciparum and L. major as
examples, we investigate the extent to which HMM/HMM comparisons can identify new domain occurrences not already
identified by sequence/HMM approaches. We show that although HMM/HMM comparisons are much more sensitive than
sequence/HMM comparisons, they are not sufficiently accurate to be used as a standalone complement of sequence/HMM
approaches at the genome scale. Hence, we propose to use domain co-occurrence — the general domain tendency to
preferentially appear along with some favorite domains in the proteins — to improve the accuracy of the approach. We
show that the combination of HMM/HMM comparisons and co-occurrence domain detection boosts protein annotations. At
an estimated False Discovery Rate of 5%, it revealed 901 and 1098 new domains in Plasmodium and Leishmania proteins,
respectively. Manual inspection of part of these predictions shows that it contains several domain families that were missing
in the two organisms. All new domain occurrences have been integrated in the EuPathDomains database, along with the
GO annotations that can be deduced.
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Introduction
With the continuous improvement of genome sequencing
technologies, an increasing number of new genomes are emerging
everyday, enhancing basic knowledge on the diversity of organisms
and providing valuable data to understand their biology and
evolutionary relationships. A survey of the Uniprot database
indicates, however, that this knowledge is highly unbalanced, with
most of sequenced Eukaryotes being related to Plant and Unikont
super-groups (see Figure 1). Since functional annotation tools have
been developed based on this wealth of unbalanced data, they
show limits when applied to the exploration of divergent genomes
[1,2]. This is especially true for protein domains, as illustrated in
Figure.1 Domains occupy a key position among the relevant
annotations that can be assigned to a protein. Protein domains are
sequential and structural motifs that are found in different proteins
and in different combinations and, as such, are the functional
subunits of proteins above the raw amino acid level [3]. Protein
domain composition provides strong clues regarding protein
function. Indeed, two thirds of mono-domain proteins having
the same domain also have the same function. Likewise, 35% of
multi-domain proteins having one common domain present
similar functions, while this rate increases to 80% when they
share two common domains [4]. Protein domains also provide
meaningful information for comparative genomics [5,6] as well as
for studying protein-protein interactions [7].
Several approaches and databases have been developed to
define and identify domains. One of the most widely used domain
schemes is the Pfam database [8]. The Pfam 26.0 release offers a
large collection of 13672 domain families. Each family in Pfam is
represented by a Hidden Markov Model (HMM) of a multiple
sequence alignment [9]. HMMs model both the conserved
positions and gaps (insertions and deletions) of the multiple
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alignment [10]. HMMs are classically used as sequence/profile
approaches to recognize homology and decipher family member-
ship. When analyzing a new protein sequence, each Pfam HMM is
used to compute a score measuring the similarity between the
sequence and the domain using HMMER software [11]. If the
score is above a given threshold provided by Pfam (each domain
has its own recommended score threshold), then the presence of
the domain can be asserted in the protein. However, when applied
to organisms showing high evolutionary distance from the classical
models which served in the construction of the HMMs, this
strategy may miss several domains [12,13]. This is the case for
most eukaryotic pathogens, such as the Leishmania and Plasmodium
species, where around 80% of the amino acids in proteins are not
covered by any domain identified so far.
A significant improvement over sequence/profile approaches
has been accomplished by profile/profile methods [14,15]. In
these approaches, profiles not only model the domain families but
also the query protein sequences. It has been shown that these
approaches are more sensitive and can detect remote homologues
missed by sequence/profile comparisons [16]. Indeed, a profile
built from an alignment of homologous proteins enables weighting
of the information brought by each position of the query sequence,
by distinguishing conserved from non-conserved positions [14].
HHPRED is one of the most recent profile/profile comparison
approaches [16]. It enables comparison of an HMM built on a
protein alignment against an HMM database like Pfam. Given a
query sequence, HHPRED first generates a multiple sequence
alignment (MSA) of related sequences through an iterative
approach like PSI-BLAST. This MSA is then transformed into a
query HMM which is compared against the HMM database.
HHPRED is one of the best performing methods for fold
recognition and domain boundary prediction [15–17]. However,
although the HHPRED approach is widely used in the protein-
structure prediction community to identify remote homologues
with known 3D-structure, it is seldom used to annotate a whole
new genome and to help predict the function of its proteins. For
this task, sequence/profile comparison remains the gold standard
method.
Here we use HHPRED to help annotate proteins of two main
human pathogens, the kinetoplastid Leishmania major, that causes a
cutaneous form of leishmaniasis, and the apicomplexan Plasmodium
falciparum which is responsible for the deadliest form of human
malaria. More specifically, our aim is to use HHPRED to identify
new domain occurrences not already identified by HMMER using
standard thresholds on these two species. We show that although
HHPRED outperforms HMMER in terms of sensitivity for
identifying divergent occurrences, it is not sufficiently accurate to
be used as a standalone annotation tool on these particular
domains. Hence, a post treatment is required to be able to
distinguish between true and false positives. We propose to use
domain co-occurrence property for this purpose. The co-
occurrence property results from the tendency of most protein
domains to preferentially appear along with few favorite domains
in the same protein. This enable us to assess the occurrence of a
particular domain in a protein by looking at the other domains of
the same protein. We present the results achieved by this
combined approach on L. major and P. falciparum species, and we
show that it greatly improves the domain coverage and the
functional annotations that can be attached to these organisms.
Interestingly, many new domain families that had never been seen
before in these organisms were discovered. We discuss these results
and give a few examples that illustrate the new insights that can be
Figure 1. Number of sequenced genomes and domain coverage in the Eukaryote tree. This figure reports the number of genomes entirely
sequenced in each of the 5 supergroups of the Eukaryote tree [58]. In each group, a few sequenced genomes are provided as example, along with
statistics relative to Pfam domains (release 26): the proportion of proteins where at least one Pfam domain has been identified using recommended
Pfam score thresholds (above), and the proportion of amino acids covered by a Pfam domain (below). Most of the genomes sequenced to date
belong to the Unikont (241) and plant (60) super-groups. We can see that there is a marked difference in the protein domain coverage between these
groups and the three other groups: while the proportion of proteins where at least one known Pfam domain is usually above 70% in Unikonts and
plants, it lies between 50% and 60% in the other groups. Similarly, while the proportion of amino-acids covered by a Pfam domain is often above 40%
in plants and Unikonts, it is around 22% in the other supergroups.
doi:10.1371/journal.pone.0095275.g001
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deduced from these predictions and their relevance for improving
the understanding of the biology of these human pathogens.
Results
The aim of this work is to boost Pfam domain predictions using
profile/profile comparison in order to enrich our knowledge on
the protein domain catalogue (and hence protein functions) of the
two major pathogens L. major and P. falciparum. All Pfam domains
that can be identified by HMMER with the recommended score
thresholds are considered as known in the following, and our aim is
to identify new domain occurrences. Alignments were done both
in global (i.e. the alignment extends up to the beginning and end of
the Pfam HMM) and local mode (i.e. alignments on domain
fragments are allowed). Contrary to previous HMMER versions,
the last HMMER version 3.0 only handles local alignments.
Hence, we used HMMER version 2 to determine the known
domain occurrences in global alignment mode. Moreover, as the
Pfam26 HMMs cannot be handled by HMMER2, we used the
Pfam23 release instead of Pfam26 for the global mode exper-
iments. L. major and P. falciparum protein sequences were
downloaded from Trytrip (http://tritrypdb.org/) and PlasmoDB
databases (http://plasmodb.org/), respectively. Each protein
sequence was first transformed into an HMM by computing a
multiple alignment of homologous sequences. This was done in
two ways. The first approach (hereafter denoted as phylum specific)
involves using only homologous sequences of species belonging to
the same phylum as the target organism—for P. falciparum we use 6
Apicomplexa, and 6 Trypanosomatidae for L. major (see Methods).
The second approach (phylum non-specific) involves using the
HHBlits approach [18] on the whole Uniprot database. HHBlits
proceeds in a Psiblast-like manner by iterative sequence searches
(see Methods). Once all HMMs were built, they were compared to
Pfam HMMs using the hhsearch procedure. hhsearch computes a
score for each HMM pair [16]. This score is an adaptation of the
log-odds score used for sequence/HMM comparison [11] which
maximizes the co-emission probability, i.e. the probability that the
two HMMs will emit the same sequence of residues [16]. As in
most sequence similarity search programs, the significance of the
score was estimated via an e-value representing the expected
number of random sequences that would achieve an as high score
[16]. All matches below a predetermined e-value threshold were
considered for the following. Each ‘‘match’’ actually corresponds
to an alignment between a part of the protein HMM and a part (in
local mode) or the whole (in global mode) Pfam HMM. From this
alignment, we first deduced the alignment between the Pfam
HMM and the query protein sequence. Then, all matches
overlapping a known domain on the protein sequence were
removed. Similarly, when two matches overlapped, the one with
the greatest e-value (i.e. the least likely domain) was removed. The
remaining matches are hereafter denoted as potential domains.
HMM/HMM comparisons do not ensure high accuracy
predictions
First, we wanted to estimate the overall quality of new
predictions achieved by HHPRED. Several sets of potential
domains of increasing size were formed using e-value thresholds
ranging from 0:001 to 50. We used the procedure we proposed in
N. Terrapon et al. [19] to estimate the False Discovery Rate (FDR)
associated with each set of potential domains. The FDR estimation
procedure is based on the well known tendency of domains to co-
occur together on the same proteins [20]. A detailed description of
this method is given in the Methods section. For comparison, we
also ran HMMER2 (for the global mode) and HMMER3 (for the
local mode) with various loose e-value thresholds. The same
filtering procedure as that used for the HHPRED matches was
applied to remove conflicting and overlapping matches identified
by HMMER. Figure 2 reports the number of new domains
identified at a given FDR by HHPRED (using the phylum non-
specific approach) and HHMMER in both modes and on both
species. As expected, for both approaches, when the e-value
threshold increases, more domains are discovered, but the FDR
associated with the predictions also increases. For low e-value
thresholds, the number of new predictions is too low to provide
reliable FDR estimation and it is difficult to precisely assess the two
approaches based on these values. However, HHPRED does not
seem to achieve accuracy below the 10% FDR threshold on the L.
major proteome. Note that this observation concerns a very specific
case: namely, all well-conserved domains have been already
identified, and the method is challenged on the difficult cases only.
Hence, it does not imply that HHPRED lacks accuracy for the
general case. Most importantly, we can see in the figure that for
moderate and high e-value thresholds, the two approaches show
very different results, and HHPRED detects a higher number of
domains than HMMER at same FDR. Although HHPRED does
not ensure high precision results, it is more sensitive than
HMMER at moderate and low precision. Hence, provided that
we can filter out the false positives, numerous new domain
occurrences can be expected from HHPRED predictions. At the
genome scale, this kind of post-treatment must be done in a fully
automatic way, and we propose to use the CODD procedure [13]
for this purpose.
HMM/HMM comparisons along with co-occurrence
detection achieve high sensitivity and accuracy
The CODD procedure is a computational approach which
enables us to select the most likely domains among a set of
potential domains, while controlling the false discovery rates
associated with the predictions. Like the FDR estimation method
used above, CODD relies on the tendency of the domains to
appear preferentially with few other domains. The principle is as
follows (see Method for details). First, from the whole set of
annotated Uniprot proteins, CODD identifies domain pairs that
are highly co-occurrent, i.e. that are observed in the same proteins
a significantly higher than expected number of times. These
domain pairs are stored in the list of Co-occurring Domain Pairs
(CDP). Next, given a set of potential Pfam domain occurrences,
CODD selects those that form, with another domain of the same
protein, a pair in the CDP list. Domains selected this way are
assigned as being certified. Three certification types can be
considered. The first and most accurate one is to use already
known Pfam domains of the protein to certify the presence of the
potential domains. A complementary solution is to use the other
known InterPro (i.e. non-Pfam) domains. This usually increases the
number of certifications. However, because of the heterogeneity of
the InterPro database, the certifications achieved this way may be
of lower quality than those achieved with Pfam domains. These
first two solutions certify domains solely in proteins in which at
least one domain is already known. To overcome this limitation, a
third solution is to certify the potential domain by another
potential domain of the protein. With this solution, all pairs of
potential domains of the protein are enumerated, and the two
domains are certified if the pair belongs to the CDP list. Finally,
CODD uses a shuffling procedure to provide an estimate of the
FDR associated with the certified domains [13]. Namely, CODD
randomly shuffles potential domains of all proteins and applies the
same certification process on these random domains. The number
of certifications achieved on random data are compared to those
Identification of Divergent Protein Domains
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Figure 2. Sensitivity and accuracy of HHPRED and HMMER for P. falciparum and L. major. Number of new domains (x-axis) identified by
HHPRED (green) and HMMER (blue) using local (left) and global (right) alignments for various FDRs (y-axis). For each approach, the two plain lines
represent an upper and lower FDR estimate (see Methods for details). Dashed lines represent the standard error associated with these two estimates.
For the sake of clarity, only the standard error above (resp. below) the upper (resp. lower) FDR estimate are represented here.
doi:10.1371/journal.pone.0095275.g002
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done on real data, and this serves as the basis of the FDR estimate
(see Methods).
We first thought to assess this approach on the already known
domains using a cross-validation procedure. We selected the
proteins of P. falciparum and L. major where at least two Pfam
domains were already known. This represents 561 and 913
proteins in P. falciparum and L. major, respectively. Then, we
randomly discarded one domain of each protein. HMMER and
HHPRED (with the phylum non-specific approach) were ran to
detect the potential domains below a predetermined e-value
threshold, and the CODD procedure was applied, using the
remaining known domains of each protein for the certification.
The FDR associated with the predictions was estimated, and we
computed the number of discarded domains that are recovered as
well as the number of new domains that are discovered. Table 1
reports the results achieved at 3% FDR. For P. falciparum, around
98% of the domains predicted by HMMER+CODD belong to the
discarded known-domains, and 437 out of the 561 discarded
domains (78%) are recovered. For HHPRED+CODD, the results
are very different: 94% of the discarded domains are recovered,
while 300 certified domains are completely new. To get a rough
idea about the number of false positives in both approaches, we
computed the number of new domains that overlap a discarded
domain. For HMMER+CODD this number equals zero, which
was expected because all known domains (and hence the discarded
ones) were identified with HMMER. For HHPRED+CODD, this
number equal 2, which represents 0.6% of the 300 new domains,
and 0.2% of the total number of certified domains, i.e. far less than
the 3% estimated FDR. Similar results are achieved on L. major.
We then ran the CODD procedure on all potential domains
detected by HHPRED—with both the phylum specific and non-
specific approaches—using already known Pfam domains for the
certifications. This was done in the local and global alignment
modes of HHPRED. Figure 3 summarizes the results achieved on
L. major and P. falciparum in both modes and using different e-value
thresholds. For each threshold, the number of certified domains
among the potential domains below this threshold was computed,
and the FDR associated with these predictions was estimated. For
comparison, we also included the results achieved by CODD on
new domains predicted by HMMER2 (global mode) and
HMMER3 (local mode) for different e-value thresholds. As we
can see, and in accordance with our first test, HHPRED greatly
outperforms HMMER when used in conjunction with CODD.
Moreover, the CODD procedure improves the accuracy of the
approach, and FDRs as low as 5% can now be achieved.
The phylum specific and non-specific approaches approaches
give close results in terms of accuracy. The non-specific approach
outperforms the specific one for Leishmania whereas the species-
specific approach achieves better results for Plasmodium proteins.
This can be explained by the fact that homologous proteins in
Leishmania species usually have high sequence identity. Hence,
the multiple alignments built from these sequences may lack
diversity. The same trend holds for the two other types of
certification (non-Pfam and potential domains, see Figures S1 and
S2), except that the FDR does not always achieve the 5%
threshold for these certifications.
Table 2 summarizes the results achieved at 5% and 10% FDR
for the different certification approaches on P. falciparum and L.
major. Overall, 901 and 1098 new non-redundant domains were
predicted at 5% FDR on the two organisms. ‘‘Non-redundant’’
means here that only one occurrence of each domain family is
considered for each protein—occurrences matching a domain
family already known in the protein are not considered, and
multiple occurrences of the same family are counted only once. In
comparison with the 4423 and 6162 non-redundant known Pfam
domains of these organisms, this corresponds to an increase of
20% and 17:8% for P. falciparum and L. major, respectively. The
majority (about 90%) of certified domains identified by HMMER
were also identified by HHPRED. Interestingly, several predicted
domains had never been seen in the studied species (218 for L.
major and 238 for P. falciparum), which corresponds to an increase of
around 12% of the domain diversity for both organisms.
One issue we have eluded so far concerns the specificities of the
domain combinations in species like P. falciparum and L. major.
Domain pairs in the CDP list have been selected on the basis of the
whole set of Uniprot proteins. Because P. falciparum and L. major
likely possess specific domain-combinations, a question remains
about the impact of these specificities on the certification process.
First, it is important to note that a combination absent from the
CDP list does not totally impede the certification of the domains
involved in this combination: in proteins with more than two
domains, when a domain A cannot be certified by a domain B
because the pair (A,B) is not in the CDP, it may still be certified by
a third domain. To go further in the analysis, we enumerated all
domain combinations present in at least one protein of P. falciparum
and L. major, and compared it to the domain combinations found
in any Uniprot proteins restricted to Vertebrates, Fungi, Plants,
Bacteria, and Archaea. The number of domain pairs present in P.
falciparum and L. major are 976 and 1008, respectively. Among
these, 96 and 159 are not found in the other phyla. We then
identified the highly co-occurrent domain pairs of P. falciparum and
L. major using the same procedure as the one used to select the
CDP list. With a p-value of 1%, we found 834 and 922 highly co-
occurrent domain pairs in P. falciparum and L. major, respectively.
Among these, only 19 and 41 are missing in the original CDP list,
respectively.
Table 1. Cross-validation experiments on P. falciparum and L. major.
# total certif. # recovered domains # overlaps
P. falciparum (561) HMMER+CODD 448 437 (78%) 0
HHPRED+CODD 828 528 (94%) 2
L. major (913) HMMER+CODD 679 679 (74%) 0
HHPRED+CODD 1345 838 (92%) 7
The test was done on the 561 and 913 proteins of P. falciparum and L. major that have at least two known Pfam domains, respectively. The table reports the number of
domains identified by HMMER and HHPRED that are certified by CODD at 3% FDR. Columns ‘‘# total certif.’’ and ‘‘# recovered domains’’ reports the total number of
certified domains and the number of discarded domains that are recovered, respectively. Column ‘‘# overlaps’’ reports the number of newly certified domains that
overlap a discarded domain.
doi:10.1371/journal.pone.0095275.t001
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Figure 3. Sensitivity and accuracy of HHPRED+CODD and HMMER+CODD using the known Pfam domain occurrences for
certifications. This figure reports the number of new domains (x-axis) certified by HHPRED+CODD (in orange and green for the phylum specific and
non-specific approaches, respectively) and HMMER+CODD (blue) using local (left) and global (right) alignments for various FDR thresholds (y-axis).
doi:10.1371/journal.pone.0095275.g003
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GO annotations transfer
We next investigated GO annotations that could be deduced
from all newly identified domains. Some domains have been
associated with specific GO terms by the InterPro consortium.
The policy is to associate with a given domain the annotations
shared by all annotated proteins possessing this domain. This
stringent policy potentially misses numerous domain-annotation
associations, because a single protein possessing a domain D but
erroneously lacking annotation A may prevent the D{A
association. Hence, we chose to relax the 100% threshold.
Namely, we looked for all D{A associations where at least 95%
of annotated proteins with domain D also have annotation A.
2466 domains can be annotated in this way. Moreover, we
extended the strategy to domain combinations (as described in
[21]), and looked for additional GO terms that could be deduced
from the combination of two domains. To this end, we
enumerated all Pfam domain pairs in the proteins of Swiss-Prot,
and identified, for each combination, the GO terms shared by
95% annotated proteins where the pair was present (only pairs
observed in at least 5 annotated proteins were considered). We
found 3460 Pfam domain pairs associated with at least one specific
GO annotation. All associations between domain combinations
and GO terms are available in Table S1. We then investigated
GO annotations that could be deduced from these association in
the two species. Table 3 provides, for each species, the number of
known annotations, the number of annotations that can be
deduced from the known protein domains using our associations,
and the number of annotations brought by the new domains (5%
FDR) either solely or in combination with another (known or new)
domain. In this latter category, we distinguish between annotations
that were already known or that could be deduced from the
already known domains, and the really new annotations brought
by our domain predictions. Altogether, the new domains brought
7089 and 9128 annotations for P. falciparum and L. major,
respectively. Among these, 5824 (82%) and 7112 (80%) confirm
already known annotations or annotations deduced from known
domains, while 1265 (18%) and 2016 (20%) are completely new.
One point that is important to bear in mind is the question of
the functional conservation of the divergent domains identified by
our approach. It is a well known fact that the functional similarity
of two homologous proteins is generally a function of their
sequence similarity (see for example [22]). Hence, although the
divergent domain occurrences identified by the HHPRED+
CODD approach likely belong to the same functional category
as the sequences used to define the domain families of Pfam, it is
important to note that they may have different specific functions.
Newly predicted domains
All new domain occurrences are available in Tables S4 and S5,
and have been integrated in the EuPathDomains database (http://
www.atgc-montpellier.fr/EuPathDomains/), along with the GO
annotations that can be deduced from all these new domains.
EuPathDomains is a protein domain database dedicated to most of
the eukaryotic pathogens present from the EuPathDB portal
(http://eupathdb.org/eupathdb/).
A survey of knowledge gained by the HHPRED+CODD
approach can serve as a starting point for developing new
hypotheses to gain further insight into the biological mechanisms
of these parasites. Hence, we sought to analyze and characterize
the specificities of newly discovered domains and their contribu-
tion to the understanding of parasite biological functions. We then
tried to assess the functional relevance of these novel annotations
based on the known and predicted properties of the corresponding
protein in each parasite. For this purpose, we performed a detailed
case by case manual analysis of the new domains families observed
in each species. As shown in table 2, with an FDRƒ10%, a total
of 1096 and 1732 domains were identified in P. falciparum and L.
major proteins by combining CODD and HHPRED in local
alignment mode, respectively. For a first investigation we chose to
focus our discussion on the domains identified by global alignment
Table 2. New Pfam domains (release 26) identified at 5% and 10% FDR.
Pfam Interpro Pot. All
P. falciparum # dom. 621/621 2/727* 485/581 901 (20.3%)/1096 (24.7%)
new fam. 181/181 2/214* 125/155 238 (13.4%)/304 (17.1%)
L. major # dom. 1098/1098 2/123* 2/972 1098 (17.8%)/1732 (28.1%)
new fam. 218/218 2/27* 2/140 218 (10.8%)/287 (14.2%)
The table reports the number of new domains identified by HHPRED (local mode, phylum non-specific approach) and CODD for the three certification types: known
Pfam domains (Pfam), known InterPro non-Pfam domains (Interp), potential domains (Pot). ‘‘All’’: results achieved when combining the 3 types. ‘‘# dom.’’: number of
new domains identified. ‘‘new fam.’’: number of domain families that were not previously known in any protein of the organism. In each cell, the left and right numbers
report the result at 5% and 10% FDR, respectively. Column ‘‘All’’: The number in parenthesis reports the proportion of already known domains or family this represents.
*For the certifications by Interpro domains, this is the number of domains identified at 12% FDR because no FDR below 10% can be achieved by this certification type.
doi:10.1371/journal.pone.0095275.t002
Table 3. New GO annotations at 5% FDR.
# known GO # GO known dom. # GO new dom.
P. falciparum 15661 3228 1265 (5824)
L. major 11958 6750 2016 (7112)
‘‘# known GO’’ is the number of known GO annotations from EuPathDB; ‘‘# GO known dom.’’ is the number of GO annotations that can be deduced from already
known domains; ‘‘#GO new dom.’’ is the number of new GO annotations that can be deduced from new domains. Numbers in parenthesis report the number of
annotations that confirm already known annotations or annotations deduced from known domains.
doi:10.1371/journal.pone.0095275.t003
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and that had never been observed on any protein of the studied
organism, since they are likely to be the more relevant in terms of
functional novelty. To further reduce these examples to a number
that can be handled manually, we chose to examine only domains
identified by the phylum specific approach and which are not
identified by HMMER+CODD at 10% FDR. This represents a
set of 36 and 37 domains in P. falciparum and L. major, respectively.
In our analyses, we considered known functions of the protein on
which the domain was found. Particular attention was given to the
position in the protein sequence where the novel domain was
discovered as well as to the description and GO annotations
associated with this domain. We then tried to investigate the
functional relationship with the biological function of the protein.
For some of these predictions, we found direct support in the
literature. We also took into consideration other species where the
domain is known and tried to find common points and
explanations that could help to understand the association of this
domain to the protein. In the case of hypothetical proteins, this
may suggest the attribution of new functions. When a predicted
domain could be specific to one developmental stage, we looked at
the transcriptional profiles of the protein. From all this informa-
tion, we tried to infer biological knowledge that could be gained
from these predictions. We discuss below several examples that
have been found in the two species. Interested readers can find the
full analysis in Tables S2 and S3.
Analysis of domains discovered in Plasmodium
proteins. At first sight, we noticed that the majority (about
90%) were in agreement with the global functional knowledge of
the corresponding proteins, providing additional or refined
features mainly consistent with already known protein domains
or functions. For example, a WH2 domain known for its
interaction with actins, was detected in the protein PFL0925w,
currently named ‘‘formin 2, putative’’ in PlasmoDB.
In some occurrences, the new domains (for example, DENN and
TFIID_90k) do provide or precise functions to proteins in which
the previously identified domains were either not very informative
or had no precise biological function attached to it (i.e. WD40).
WD40 domains, which are among the 10 most currently found
domains in eukaryotic proteins, indicate interaction properties
with other proteins, peptides or nucleic acids and hence, WD40
proteins are involved in a wide variety of functions such as signal
transduction, cytoskeleton assembly, RNA maturation, chromatin dynamics,
vesicular trafficking, etc. [23]. The possibility, offered here, to identify
additional domains paired with WD40 domains is therefore
invaluable to better qualify the functions of this otherwise highly
diverse WD40 proteins family. Example for such a refinement are
listed in Table S2 and are also illustrated further in the text for
protein PF3D7_1138800.
A series of new domains putatively involved either in invasion or
egress were also discovered. A ‘‘Mar sialic bdg’’ domain was
indentified in PCRMP2 (MAL7P1.92), that could be used by
salivary gland-sporozoites to invade the insect-host tissues [24], as
was found in T. gondii [25] or other apicomplexan parasites [26]. A
LysM domain was identified on PFA0130c, a member of the
‘‘serine/threonine protein kinase, FIKK family’’ that could play an
important role in erythrocyte modelling [27,28]. Indeed, LysM
domain are found in a variety of enzymes involved in bacterial cell
wall degradation [28].
A very interesting discovery concerns a DHQ_synthase domain,
that was predicted at position 1–171 of the PFB0280w protein.
DHQ stands for 3-dehydroquinate and indeed, the enzyme
encoding 3-dehydroquinate synthase activity, which is involved in the
first steps of the shikimate pathway, has yet to be identified in
Plasmodium [29] (see also Malaria Metabolic Pathways http://sites.
huji.ac.il/malaria/). The shikimate pathway allows the synthesis of
aromatic amino acids and is present in plants and microorganisms.
It has been shown to be active in Plasmodium and is considered as
an attractive drug target because it is absent from mammalian cells
[29,30]. However, proteins encoding the first 4 activities of this 7-
step pathway (DHQ synthase activity corresponds to the second step)
are still elusive in Plasmodium [29]. PFB0280w, which is currently
described as bi-functional enzyme encoding steps 5 and 6 of the
shikimate pathway—it harbours the EPSP and the SKI domains,
both involved in the shikimate pathway—, could therefore be a
malarial ortholog of the arom protein, a penta-functional enzyme
typically found in fungi. Interestingly, in T. gondii, a DHQ-synthase
domain has also been found in a penta-functional enzyme
homologous to the fungus arom protein.
Finally, this method could even provide functions for proteins
previously totally devoid of both domains and annotations, thanks
to the use of potential domains for the certification process. We
predicted, for example, the Rad21_Rec8_N and Rad21_Rec8
domains in the conserved Plasmodium protein PF14_0380 that
did not have any known GO function. Both predicted domains
suggest involvement in the mediation of sister chromatid cohesion
during mitosis and meiosis, as part of the cohesin complex. The
indication in PlasmoDB that PF14_0380 interacts with PFC0155c
protein, annotated as ‘‘DNA directed RNA pol. Subunit I’’ further
supports this hypothesis.
Analysis of domains discovered in Leishmania
proteins. As for P. falciparum, several L. major novel domains
are complementary to known protein features and confirm
functions associated with them. For example, we predicted the
Ku-c domain in the C-terminal region of the LmjF29.1050 protein,
which already possesses the Ku-N and Ku70/Ku80 domains.
Besides these predictions, several other domains suggest new
functions for proteins with no or only very general functions. As
for P. falciparum, a strikingly high number of domains in this case
were predicted in association with the ubiquitous WD40 domains.
Among the most interesting predictions, we can cite, for example,
the Rhomboid domain, predicted in the LmjF24.1580 protein.
Rhomboid domains belong to proteins of a large family of intra-
membrane serine proteases. Their conservation throughout almost
all branches of life suggests involvement in key biological events
with various functions: triggering of signaling events in Drosophila,
association with pathogenesis in protozoan parasites, and parasite
proliferation in T. gondii [31]. Rhomboid-like proteases had been
described as being localized in the secretory pathway or belonging
to mitochondria. Prior to this study, no Pfam Rhomboid domain
have been described in L. major, whereas partial Rhomboid domains
have been described in other Leishmania species. In LmjF24.1580,
the presence of a mitochondrial like N-terminal targeting sequence
suggests a putative mitochondrial function for this protein [32].
Despite their high conservation, Rhomboid proteases seem to display
different functions in distinct organisms, so it is unlikely that a
single widespread function is conserved among all species.
Examples of mitochondrial function associated with oxidative
stress signaling have been described in yeast, or in Parkinson’s
disease in humans, whereas Rhomboid proteases conserved in
extracellular pathogens have been associated with host cell
invasion or, in the case of the extracellular ameba Entamoeba
histolytica, to immune evasion [33].
Investigation of domains involved in transcriptional
regulation
Parasitic protists have often evolved transcriptional regulation
mechanisms different from classical higher-eukaryotes models
[34]. In trypanosomatids, this is partly due to the particular
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polycistronic organization of genes without a clearly identified
RNA polymerase II (RNAP II) transcription system (except for SL-
RNA). This is mainly illustrated by the absence of several RNAP II-
related transcription factors (TF). Indeed, although several basal
TFs have been identified in Leishmania species, several others seem
to be missing in these species and other trypanosomatids [35,36].
The picture is a little different in P. falciparum. While almost all
proteins necessary for the basal transcription apparatus have been
identified, there appears to be a lack of specific TFs [37]. With the
notable exception of the AP2 domain [38], most attempts for the
identification of specific TFs in P. falciparum have failed. In these
conditions, the discovery of DNA binding domains involved in
transcriptional regulation may be of great interest in P. falciparum
and L. major. We retrieved from the Pfam website a list of domains
associated with GO terms related to transcription, and searched
for occurrences of these domains in our predictions at 5% FDR
(local mode, phylum non-specific approach). We discuss below the
most interesting discoveries of this analysis in P. falciparum and L.
major.
Domains discovered in P. falciparum proteins. We
predicted, for example, a TFIID_90kDa domain known to be
found in subunits of transcription factor TFIID in the protein
PF3D7_1138800 (previously PF11_0399, PF11_0400 and
PF11_0401), annotated ‘‘conserved Plasmodium protein, unknown
function’’. Currently, this very large P. falciparum protein predicted
to be nuclear, has domain annotations solely upstream of position
1500 for a series of WD40 domains. The available proteomics data
showing tracks in diverse extracts among which nucleus is also in
agreement with the proposal that this protein could be a novel
subunit of TFIID.
The discovery of both TFIIA_gamma_N and TFIIA_gamma_C
domains on the PF3D7_0933700 protein currently annotated
‘‘conserved Plasmodium protein, unknown function’’ is of great interest.
This little protein is currently totally devoid of domain annotation
in PlasmoDB, although it has several GO annotations related to
DNA-dependent transcription. Interestingly, the TFIIA_gamma subunit
is characterized by a conserved structure, with 4 helices in the N-
terminal domain and 12 beta barrels in the C-terminal domain.
Such domains are indeed predicted for PF3D7_0933700, at the
proper position, further suggesting that this protein is indeed the
gamma subunit of TFIIA [39,40].
We also discovered a TFIIE_alpha domain in the protein
PF3D7_1145800. The general transcription factor TFIIE has an
essential role in eukaryotic transcription initiation together with
RNA polymerase II and other general factors. We also identified a
HTH_9 domain at the beginning of the protein. This protein is
currently annotated ‘‘conserved Plasmodium protein, unknown function’’,
but PlasmoDB reports GO annotations in agreement with our
observation, in particular the GO:0005673 annotation ‘‘transcrip-
tion factor TFIIE complex’’. Therefore this protein likely corresponds
to the TFIIE_alpha peptide, as suggested by our study.
Another interesting prediction was the discovery of the
Auxin_resp domain (PF06507) of the very large P. falciparum protein
PF14_0463, currently annotated ‘‘chloroquine resistance marker protein
(CRMP)’’. This domain occurs in several plant transcription
factors that are responsive to the Auxin hormone, and their
conserved structure includes a N-terminal DNA binding domain and
a C-terminal protein-protein interaction domain [41]. So far,
PF14_0463 has a single domain, PFI12047 (DNMT1-RFD, cytosine
specific DNA methyltransferase replication foci domain) at positions 793-
943, which is also a DNA binding domain. Interestingly, this
Auxin_resp domain has so far been identified in four other
Apicomplexan proteins (B9PN31_TOXGO, B6KF11_TOXGO,
B9Q8D8_TOXGO, F0VLG9_NEOCL). All of them also have a
DNMT1-RFD domain upstream, highlighting structural conserva-
tion in the phylum. In addition, PF14_0463 is currently reported
to be nuclear, and to interact with a large number of proteins,
including several nuclear proteins (PFD3D7_1464000,
PF3D7_0729400, PFD3D7_1212900), which is in accordance with
transcription factor activity. Note that GeneDB currently recom-
mends that the ‘‘chloroquine resistance marker protein’’ annotation
should be discontinued.
Two domains, RNA_pol_Rpb1-3 and RNA_pol_Rpb1-4, were
discovered in two proteins encoded next to each other by the
apicoplast genome: PFC10_API0016 and PFC10_API0017 [42].
These two proteins are currently annotated as rpoC and rpoD,
respectively. Interestingly, at present, domains RNA_pol_Rpb1-1
and RNA_pol_Rpb1-2 have been annotated for PFC10_API0016,
upstream of our newly discovered RNA_pol_Rpb1-3 domain and a
RNA_pol_Rpb1-5 domain has been annotated for PFC10_API0017,
upstream of our newly discovered RNA_pol_Rpb1-4 domain. This
discovery is another example where our new domains confirm and
further define the structure and function of an already annotated
protein. Note that the two genes encode a prokaryotic-type RNA
polymerase that is known to be split into two polypeptides in Archae
and chloroplasts [43].
Domains discovered in L. major proteins. LmjF.28.1740
is a hypothetical protein in which we identified a novel domain
called NusB. NusB is a prokaryotic transcription factor involved in
the antitermination process, i.e. the phenomenon whereby RNA
polymerases terminate transcription at specific sites or read
through terminators, which is crucial for the regulation of gene
expression [44]. While this protein acts as a monomer in Escherichia
coli, it has been described to act as a dimer in Mycobacterium
tuberculosis [45]; the dimerization might potentially be used to
maintain NusB in an inactive form until it is recruited for the
antitermination process [46].
A novel domain called CarD_CdnL_TRCF has been identified in
LmjF.32.2230. This gene is annotated as ‘‘ATP-dependent RNA
helicase putative’’ and bears domains related to this helicase function.
The CarD_CdnL_TRCF domain then adds a new function to the
protein, putatively related to a repair mechanism during
transcription. Indeed, TRCF (Transcription-Repair-Coupling Factor),
for instance, is known to bind to UvrA, the DNA damage recognition
protein, in order to increase strand repair during transcription [47].
In trypanosomatids, the necessity to maintain an efficient repair
mechanism is described in particular for the kinetoplastid DNA
(kDNA), which is subjected to intensive endogenous oxidative
damage. The efficiency of kDNA maintenance is thus a crucial
mechanism to repair oxidative damage [48].
The LmjF.33.2810 gene is annotated as a ‘‘transcription elongation
factor-like protein’’. We were able to complement this annotation by
the Med26 domain (PF08711). Med26, or TFIIS helical bundle-like
domain, is present in the N-terminal part of the TFIIS protein.
This protein, also called Med26 protein, is part of a large complex
of 33 proteins called Mediator, largely conserved from plants to
humans [49]. Mediator is able to link DNA transcription regulators
(activators and repressors) to the pol II initiation machinery mainly
through physical interaction with DNA specific signals and pol II
subunits [50]. TFIIS seems to be a multifunctional protein acting
as a transcription elongation factor involved in increasing the
RNAP II transcription rate as well as a protein involved in controlling
the early stages of the transcription cycle [51]. The Med26 domain
has also been found in LmjF.33.2820, a hypothetical protein
bearing TFIIS-associated interpro non-PFAM domains. Interest-
ingly, we also discovered a TFIIS C domain in this protein, which
is a zinc finger motif that is also found in the TFIIS.
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As for P. falciparum, our approach also allowed us to relate
proteins already involved in the transcription process to novel
domains associated with RNAP II transcription. RPB1 is the largest
subunit of pol II, constituting, through different subunits, the DNA
binding domain of pol II. We identified the novel RPB1_1 domain
in LmjF.16.1350, annotated as the DNA-directed RNA polymerase I
largest subunit and already bearing different RPB1 domains.
Additionally, TF_Zn Ribbon is a zinc finger motif found in transcription
factor IIB (TFIIB), one of the subunits involved in eukaryotes in
promoter recognition and interaction with pol II. This domain has
been identified in the LmjF.25.0440 protein, annotated as a putative
transcription factor.
Discussion
We have shown that profile/profile approaches like HHPRED
can boost protein domain annotation. This is especially useful for
species that have greatly diverged from the classical plant and
Unikont model organisms, like most eukaryotic pathogens.
Although the approach does not seem to be sufficiently accurate
to be used as a standalone tool for identifying the divergent
domain occurrences that have not been identified by classical
sequence/profile approaches, it is much more sensitive than these
latter, and actually enhances the annotations of several hundred
proteins when used in combination with the co-occurrence
domain discovery approach (CODD). For P. falciparum and L.
major, HHPRED+CODD enabled us to discover 901 and 1098
new domains at an estimated FDR of 5% FDR, respectively.
One issue of our approach is that it applies to multi-domain
proteins only. First, it is worth noting that these proteins are
thought to represent a large part (around 80%) of Eukaryotic
proteins [52]. Moreover, the term ‘‘domain’’ is used here in a very
broad sense. Besides long domains, which independently folds into
a particular 3D structure, the term also encompasses motifs as
short as a dozen amino-acids—for example, more than 300
domain families have less than 30 amino acids in Pfam. However,
it remains true that, because they are composed of a single
domain, a significant number of proteins cannot be annotated by
our approach. For these proteins (and the other ones as well), a
solution would be to fit the Pfam HMMs to the specificities of the
target proteome, and to rescan the protein sequences with these
new models. A simple and efficient solution for this is to
incorporate the domains occurrences already identified in the
species into the Pfam seed alignment, and to train a new HMM on
this alignment [19].
All predictions along with the GO annotations that can be
deduced have been integrated in the EuPathDomains database, a
protein domain database dedicated to eukaryotic pathogens. Close
analysis of some of the predictions involving Pfam domain families
that were unknown in P. falciparum and L. major showed that the
approach identifies key domains that were missing to date. For
example this analysis revealed one of the missing enzymes involved
in the first step of the shikimate pathway, an attractive drug target
in P. falciparum because of its absence in mammalian cells.
Importantly, several predictions reveal new domains in proteins
currently devoid of any domain annotation. This is for example
the case for the P. falciparum protein PFI630c, which is the gamma
subunit of TFIIA according to our analysis. Our approach is fully
automatic and can be applied on any genome. Hence, it could be
of great help for annotating all genomes that are phylogenetically
distant from classical model organisms, and we intend to apply it
to all other pathogens in EuPathDomains.
Methods
HHPRED predictions
We used HHPRED from the HH-suite 2.0 in our experiments.
First, each query protein sequence was used to build a multiple
sequence alignment (MSA). This was done using two approaches,
using either only the homologous proteins in close species, or every
sequenced homologue, via the HHblits method [18].
Phylum specific approach. For L. major, six species were
included: four Leishmania species (L. major, L. infantum, L.braziliensis
and L. mexicana) and two Trypanosoma species (Trypanosoma cruzi and
Trypanosoma brucei) (http://tritrypdb.org/tritrypdb/). For P. falci-
parum, six species were analyzed: P. falciparum, P. vivax, P. yoelii,
P.berghei, P. chabaudi and P. knowlesi. For each L. major and P.
falciparum protein, we extracted its homologs in the set of selected
closest species from the OrthoMCL database [53]. 99:4% of L.
major and 99:2% of P. falciparum proteins have at least one
homologue in the selected species, respectively. The majority of L.
major proteins (95%) have orthologs in the three other Leishmania
species. For P. falciparum, 72% of proteins have homologs in the
five other Plasmodium species. When a protein has paralogs in the
query species (16% of P. falciparum proteins and 15% of L. major
proteins), these paralogs were also considered. Each query protein
sequence was aligned against its homologs using Muscle [54].
Phylum non-specific approach (HHblits). HHblits pro-
ceeds in a Psi-blast-like manner by iteratively aligning additional
homologous sequences on the query protein. HHblits was run with
default parameter values—3 iterations, local alignment mode, and
1:e{3 e-value threshold. The only difference is that we required a
20% minimal sequence identity threshold with the query sequence
instead of the default 0%-threshold to ensure that only real
homologues are included in the MSA.
All generated MSAs were then transformed into an HMM
profile using the hhmake procedure of HHPRED. hhmake was run
with default parameters, except for the maximum sequence
identity parameter that we set at 100 because the sequence
identity is very high especially in Leishmania proteins. Each HMM
was then compared with all HMMs of the Pfam database. We
considered, for the following experiments, hits with e-values
ranging from 0.1 to 10. As explained in section Results, the
experiments were done using local and global alignment modes,
using Pfam 26 and Pfam 23 HMMs, respectively. From each
alignment of a protein-HMM and a domain-HMM, the position
of the potential domain on the query sequence was deduced. Each
potential domain overlapping an already known domain of the
protein (i.e. all domain occurrences identified by HMMER below
the stringent score threshold provided by Pfam) was discarded.
Similarly, when two potential domains overlapped on the protein
sequence, the one with the greatest e-value (i.e. the least likely) was
removed.
FDR estimation
Let L be a set of new domain occurrences identified by
HMMER or HHPRED. We want to estimate the FDR associated
with L, i.e. the probability Pr(d~false) for d[L. For this, we used
the approach proposed in Terrapon et al. [19]. This procedure
utilizes the tendency of the domain to appear preferentially with a
few other favorite domains in the same proteins. The first step is to
identify, from the whole set of annotated Uniprot proteins, domain
pairs that are conditionally dependent, i.e. that are observed in the
same proteins a significantly higher number of times than expected
at random. This is achieved with the Fisher’s exact test to cope
with potentially small sample sizes. A p-value is computed for each
domain pair, and pairs below a given threshold are stored in a set
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C of Co-occurring Domain Pairs (CDP). Next, from the target-
species proteins that possess both known and potential domains,
we build a list of (known-potential) domain pairs L, by randomly
associating each new domain with one of the already known
domains of the same protein. We let (dk,dn) denote a pair of
(known,potential) domains of L. The list L is used to estimate the
FDR of (L,e). We assume that the proportion of false positives
among the new domains dn of L is generally the same as in all
domains of L. In particular, this assumes that, for a given e-value
threshold, the proportion of false positives in domains of multi-
domain proteins (those that are in L) is the same as in domains of
mono-domain proteins (that are not in L). Although domains of
mono- and multi-domain proteins are usually different, they
generally share the same amino-acid composition, and there is no
reason to believe that HMMs are more prone to false positives for
either type.
Let jLj be the number of pairs in L. Now, we let T denote the
probability that a pair in L belongs to the set of CDPs C, given
that the potential domain is a true positive. Similarly, F is the
probability that a pair in L belongs to C, given that the potential
domain is a false positive. We can express the expected number of










jLj is known, and E½jLC j is estimated by the observed number
of pairs in L that belong to C. For F , a list L’ is created by
randomly permuting new domains of the pairs in L. This is
equivalent to randomly permuting the new domains in the
proteins of the target species, and thus simulates a situation where
almost all new domains are likely false positives. F is estimated by
the proportion of L’ pairs that are in C. The procedure is repeated
several times and averaged to obtain a better estimate. For T , we
use the known domain occurrences. A list L’’ is created from
(known,known) domain pairs observed in proteins with at least two
known domains. This simulates the situation where all new
domains are true positives, and T is estimated by the proportion of
L’’ pairs that are in C.
F and T have very different estimated values. The value of F
lies between 1% and 2%, independent of the method and E-value
threshold. Hence, we used the value F~1% in Figure.2 For T , we
generated several lists of (known,known) domain pairs and
observed that the estimated T lies between 96% and 99%.
Although these two values are relatively close, they may lead to
different FDR estimates, especially for low FDRs. Thus, we
provide two FDR estimates in our experiments: one computed
with T~96% and one with T~99%.
Moreover, we used a bootstrap procedure [55] to measure the
standard error of the FDR estimates. A bootstrapped list Lb is built
by randomly sampling with replacement jLj pairs of L. From this
list, we compute a new FDR estimate FDRb using the procedure
described above, and the entire procedure is repeated a large
number of times B (here B~500). We then have a sample of B
independent bootstrap replications of the FDR estimate, and we
use the standard deviation of this sample as an estimate of the
standard error. In Figure 2, this error is computed both for the
T~96% and T~99% FDR estimates and is represented with
dashed lines.
Co-Occurrence Domain Discovery
CODD is a computational approach which enables us to select
the most likely occurrences among a set of potential domain
occurrences (with possibly numerous false positives), while
controlling the false discovery rates associated with the predictions
[56]. CODD utilises the same co-occurrence tendency used in the
FDR estimation method described above but for a different
purpose. Namely, given a set of new domain occurrences, CODD
selects those that form, together with another domain of the same
protein, a pair previously identified as being conditionally
dependent (i.e. a pair of the CDP set). The domains selected this
way are said to be certified. The certification can be done on the
basis of the already known Pfam domains of the protein, but also
on the basis of the other known InterPro (non Pfam) domains, or
even on the basis of the other potential Pfam domains of the
protein.
CODD provides an estimate of the FDR associated with the
certified domains [56]. To this end, CODD estimates the
probability of certifying a potential domain under the null
hypothesis H0 that it has been randomly predicted. This is done
through computer simulations by shuffling the potential domains
of all proteins. This creates a situation where the potential domains
are independent of the validating domains, while preserving the
domain distribution and the number of validating and potential
domains in each protein. The certification procedure is applied to
the shuffled domains, and the number of random domains
certified is computed. The entire procedure is resumed several
times (typically 1000 times) to get a reliable estimate of the
expected number of domains our procedure would certify under
the hypothesis that all potential domains are random. This
number is then used to compute an estimate of FDR of the
certification process with the formula
dFDR~
expected number of certifications under H0
number of certifications on original data
: ð2Þ
This approach is similar to that proposed in [57] to control
the FDR associated with the multiple testing of several
hypotheses.
Supporting Information
Figure S1 Sensitivity and accuracy of HHPRED+CODD
and HMMER+CODD using the known Interpro domain
occurrences for certifications. This figure reports the
number of new domains (x-axis) certified by HHPRED+CODD
(in orange and green for the phylum specific and non-specific
approaches, respectively) and HMMER+CODD (blue) using local
(left) and global (right) alignments for various FDR thresholds (y-
axis).
(PDF)
Figure S2 Sensitivity and accuracy of HHPRED+CODD
and HMMER+CODD using the potential domain occur-
rences for certifications. This figure reports the number of
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new domains (x-axis) certified by HHPRED+CODD (in
orange and green for the phylum specific and non-specific
approaches, respectively) and HMMER+CODD (blue) using local
(left) and global (right) alignments for various FDR thresholds (y-
axis).
(PDF)
Table S1 List of considered associations between
domains and GO terms.
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Table S2 List of the 36 P. falciparum domain predic-
tions that were manually analysed.
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Table S3 List of the 37 L. major domain predictions
that were manually analysed.
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(XLS)
Author Contributions
Conceived and designed the experiments: AG LB. Performed the
experiments: AG. Analyzed the data: AG IF FZG DL NT. Contributed
reagents/materials/analysis tools: AG LB. Wrote the paper: AG LB IF
FZG. Revised the manuscript: OG SBY. Initiated the project: LB OG.
References
1. Bre´he´lin L, Florent I, Gascuel O, Mare´chal E (2010) Assessing functional
annotation transfers with inter-species conserved coexpression: application to
plasmodium falciparum. BMC Genomics 11.
2. Ghouila A, Terrapon N, Gascuel O, Guerfali F, Laouini D, et al. (2010)
Eupathdomains: The divergent domain database for eukaryotic pathogens.
Infect Genet Evol 11: 698–707.
3. Richardson J (1981) The anatomy and taxonomy of protein structure. Adv
Protein Chem 34: 167–339.
4. Hegyi H, Gerstein M (2001) Annotation transfer for genomics: measuring
functional divergence in multi-domain proteins. Genome Res 11: 1632–1640.
5. Rubin G, Yandell M, Wortman J, Gabor MG, Nelson C, et al. (2000)
Comparative genomics of the eukaryotes. Science 287: 2204–15.
6. Pasek S (2007) Domain team: synteny of domains is a new approach in
comparative genomics. Methods Mol Biol 396: 17–29.
7. Ochoa A, Llina´s M, Singh M (2011) Using context to improve protein domain
identification. BMC Bioinformatics 12.
8. Finn R (2008) The pfam protein families database. Nucleic Acids Research 36:
D281–D288.
9. Durbin R (1998) Biological sequence analysis: probabilistic models of proteins
and nucleic acids. Cambridge University Press, Cambridge, UK.
10. Eddy SR (1998) Profile hidden markov models. Bioinformatics 14: 755–763.
11. Eddy SR (1996) Hidden markov models. Current Opinion in Structural Biology
6: 361–365.
12. Wardl P, Equinet L, Packer J, Doerig C (2004) Protein kinases of the human
malaria parasite plasmodium falciparum: the kinome of a divergent eukaryote.
BMC Genomics 5: 79.
13. Terrapon N, Gascuel O, Mare´chal E, Brehelin L (2009) Detection of new
protein domains using co-occurrence: application to plasmodium falciparum.
Bioinformatics 25: 3077–3083.
14. Dlakic M (2009) Hhsvm: fast and accurate classification of profile-profile
matches identified by hhsearch. Bioinformatics 25: 3071–3076.
15. Soding J, Remmert M (2011) Protein sequence comparison and fold recognition:
progress and good-practice benchmarking. Current opinion in Structural
Biology 21: 404–411.
16. Soding J (2005) Protein homology detection by hmmhmm comparison.
Bioinformatics 21: 951–960.
17. Battey J, Kopp J, Bordoli L, Read J, Clarke ND, et al. (2007) Automated server
predictions in casp7. Proteins: Structure, Function, and Bioinformatics 69: 68–
82.
18. Remmert M, Biegert A, Hauser A, Soding J (2012) Hhblits: lightning-fast
iterative protein sequence searching by hmm-hmm alignment. Nat Methods 9:
173–5.
19. Terrapon N, Gascuel O, Mare´chal E, Bre´he´lin L (2012) Fitting hidden markov
models of protein domains to a target species: application to plasmodium
falciparum. BMC Bioinformatics 13: 67.
20. Cohen G, Nussinov R, Sharan R (2007) Comprehensive analysis of co-occurring
domain sets in yeast proteins. BMC Genomics 8.
21. Forslund K, Sonnhammer E (2008) Predicting protein function from domain
content. Bioinformatics 24: 1681–1687.
22. Tian W, Skolnick J (2003) How well is enzyme function conserved as a function
of pairwise sequence identity? Journal of Molecular Biology 333: 863–882.
23. Stirnimann C, Petsalaki E, Russell R, Mu¨ller C (2010) Wd40 proteins propel
cellular networks. Trends in Biochem Sci 35: 565–574.
24. Thompson J, Fernandez-Reyes D, Sharling L, Moore SG, Eling WM, et al.
(2007) Plasmodium cysteine repeat modular proteins 1–4:complex proteins with
roles throughout the malaria parasite life cycle. Cellular Microbiology 9: 1466–
1480.
25. Hager K, Carruthers VB (2008) Marveling at parasite invasion. Trends in
Parasitology 24: 51–54.
26. Friedrich N, Santos J, Liu Y, Palma A, Leon E, et al. (2010) Members of a novel
protein family containing microneme adhesive repeat domains act as sialic acid-
binding lectins during host cell invasion by apicomplexan parasites. The Journal
of Biological Chemistry 285: 2064–2076.
27. Nunes MC, Goldring P, Doerig C, Scherf A (2007) A novel protein kinase family
in plasmodium falciparum is differentially transcribed and secreted to various
cellular compartments of the host cell. Molecular Microbiology 63: 391–403.
28. Joris B, Englebert S, Chu C, Kariyama R, Daneo-Moore L, et al. (1992)
Modular design of the enterococcus hirae muramidase-2 and streptococcus
faecalis autolysin. FEMS Microbiol Lett 70: 257–64.
29. McConkey GA, Pinney J, Westhead D, Plueckhahn K, Fitzpatrick T, et al.
(2004) Annotating the plasmodium genome and the enigma of the shikimate
pathway. Trends in Parasitology 20: 60–65.
30. Richards T, Dacks J, Campbell S, Blanchard J, Foster P, et al. (2006)
Evolutionary origins of the eukaryotic shikimate pathway: gene fusions,
horizontal gene transfer, and endosymbiotic replacements. Eukaryot Cell 5:
1517–31.
31. Santos JM, Graindorge A, Soldati-Favre D (2012) New insights into parasite
rhomboid proteases. Molecular and Biochemical Parasitology 182: 27–36.
32. Besteiro S, Williams RA, Coombs GH, Mottram JC (2007) Protein turnover and
differentiation in leishmania. International Journal for Parasitology 37: 1063–
1075.
33. Baxt LA, Baker RP, Singh U, Urban S (2008) An entamoeba histolytica
rhomboid protease with atypical specificity cleaves a surface lectin involved in
phagocytosis and immune evasion. Genes and development 22: 1636–1646.
34. Iyer L, Anantharaman V, Wolf M, Aravind L (2008) Comparative genomics of
transcription factors and chromatin proteins in parasitic protists and other
eukaryotes. Int J Parasitol 38: 1–31.
35. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, et al. (2005)
The genome of the african trypanosome trypanosoma brucei. Science 309: 416–
22.
36. El-Sayed N, Myler P, Bartholomeu D, Nilsson D, Aggarwal G, et al. (2005) The
genome sequence of trypanosoma cruzi, etiologic agent of chagas disease.
Science 309: 409–15.
37. Horrocks P, Wong E, Russel K, Emes R (2009) Control of gene expression in
Plasmodium falciparum - Ten years on. Molecular & Biochemical Parasitology
164: 9–25.
38. Balaji S, Babu M, Iyer L, Aravind L (2005) Discovery of the principal specific
transcription factors of Apicomplexa and their implication for the evolution of
the AP2-integrase DNA binding domains. Nucleic acids research 33: 3994.
39. DeJong J, Bernstein R, Roeder R (1995) Human general transcription factor
tfiia: characterization of a cdna encoding the small subunit and requirement for
basal and activated transcription. Proc Natl Acad Sci U S A 92: 3313–7.
40. Tan S, Hunziker Y, Sargent D, Richmond T (1996) Crystal structure of a yeast
tfiia/tbp/dna complex. Nature 381: 127–51.
41. Sato Y, Nishimura A, Ito M, Ashikari M, Hirano H, et al. (2001) Auxin response
factor family in rice. Genes Genet Syst 76: 373–80.
42. Wilson R, Denny P, Preiser P, Rangachari K, Roberts K, et al. (1996) Complete
gene map of the plastid-like dna of the malaria parasite plasmodium falciparum.
J Mol Biol 261: 155–72.
43. Severinov K, Mustaev A, Kukarin A, Muzzin O, Bass I, et al. (1996) Structural
modules of the large subunits of rna polymerase. J Biol Chem 271: 27969–74.
44. Weisberg R, Gottesman M (1999) Processive antitermination. J Bacteriol 181:
359–67.
45. Gopal B, Haire L, Cox R, Jo CM, Major S, et al. (2000) The crystal structure of
nusb from mycobacterium tuberculosis. Nat Struct Biol 7: 475–8.
46. Bonin I, Robelek R, Benecke H, Urlaub H, Bacher A, et al. (2004) Crystal
structures of the antitermination factor nusb from thermotoga maritima and
implications for rna binding. Biochem J 383: 419–28.
47. Selby C, Sancar A (1995) Structure and function of transcription-repair coupling
factor. J Biol Chem 270: 4882–9.
48. Passos-Silva D, Rajao M, de Aguiar PH Nascimento, da Rocha JV, Machado C,
et al. (2010) Overview of dna repair in trypanosoma cruzi, trypanosoma brucei,
and leishmania major. J Nucleic Acids 2010: 840768.
Identification of Divergent Protein Domains
PLOS ONE | www.plosone.org 12 June 2014 | Volume 9 | Issue 6 | e95275
49. Bourbon H, Aguilera A, Ansari A, Asturias F, Berk A, et al. (2004) A unified
nomenclature for protein subunits of mediator complexes linking transcriptional
regulators to rna polymerase ii. Mol Cell 14: 553–7.
50. Bourbon H (2008) Comparative genomics supports a deep evolutionary origin
for the large, fourmodule transcriptional mediator complex. Nucleic Acids Res
36: 3993–4008.
51. Pan G, Aso T, Greenblatt J (1997) Interaction of elongation factors tfiis and
elongin a with a human rna polymerase ii holoenzyme capable of promoter-
specific initiation and responsive to transcriptional activators. J Biol Chem 272:
24563–71.
52. Apic G, Gough J, Teichmann S (2001) Domain combinations in archeal,
eubacterial and eukaryotic proteomes. Journal of Molecular Biology 310: 311–
325.
53. Chen F, Mackey A, Stoeckert CJ, Roos DS (2006) Orthomcl-db: querying a
comprehensive multispecies collection of ortholog groups. Nucleic Acids
Research 34: D363–D368.
54. Edgar R (2004) Muscle: multiple sequence alignment with high accuracy and
high throughput. Nucleic Acids Research 32: 1792–1797.
55. Efron B, Gong G (1983) A leisurely look at the bootstrap, the jackknife, and
cross-validation. The American Statistician 37:pp. 36–48.
56. Terrapon N, Gascuel O, Mare´chal E, Bre´he´lin L (2009) Detection of new
protein domains using co-occurrence: application to Plasmodium falciparum.
Bioinformatics 25: 3077–3083.
57. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical
and powerful approach to multiple testing. Journal of the Royal Statistical
Society 85: 289–300.
58. Keeling P, Burger G, Durnford D, Lang B, Lee R, et al. (2005) The tree of
eukaryotes. Trends Ecol Evol 20: 670–6.
Identification of Divergent Protein Domains
PLOS ONE | www.plosone.org 13 June 2014 | Volume 9 | Issue 6 | e95275
